nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vincristine—muscle cancer	0.891	1	CrCrCtD
Rescinnamine—ACE—forelimb zeugopod—muscle cancer	0.0205	0.304	CbGeAlD
Rescinnamine—ACE—hindlimb—muscle cancer	0.00926	0.137	CbGeAlD
Rescinnamine—ACE—arm—muscle cancer	0.00884	0.131	CbGeAlD
Rescinnamine—ACE—appendage—muscle cancer	0.00794	0.118	CbGeAlD
Rescinnamine—ACE—embryo—muscle cancer	0.00264	0.0391	CbGeAlD
Rescinnamine—SLC18A2—tendon—muscle cancer	0.00228	0.0339	CbGeAlD
Rescinnamine—SLC18A2—vagina—muscle cancer	0.00212	0.0314	CbGeAlD
Rescinnamine—ACE—smooth muscle tissue—muscle cancer	0.00207	0.0308	CbGeAlD
Rescinnamine—ACE—renal system—muscle cancer	0.002	0.0296	CbGeAlD
Rescinnamine—Pigmentation disorder—Etoposide—muscle cancer	0.00196	0.0469	CcSEcCtD
Rescinnamine—SLC18A2—head—muscle cancer	0.00196	0.029	CbGeAlD
Rescinnamine—SLC18A2—testis—muscle cancer	0.00189	0.028	CbGeAlD
Rescinnamine—ACE—cardiac atrium—muscle cancer	0.00179	0.0265	CbGeAlD
Rescinnamine—ACE—bone marrow—muscle cancer	0.00151	0.0224	CbGeAlD
Rescinnamine—ACE—head—muscle cancer	0.00134	0.0198	CbGeAlD
Rescinnamine—Sunburn—Methotrexate—muscle cancer	0.0013	0.0311	CcSEcCtD
Rescinnamine—ACE—testis—muscle cancer	0.00129	0.0191	CbGeAlD
Rescinnamine—Taste metallic—Methotrexate—muscle cancer	0.00124	0.0295	CcSEcCtD
Rescinnamine—Pigmentation disorder—Doxorubicin—muscle cancer	0.00102	0.0243	CcSEcCtD
Rescinnamine—Bullous eruption—Doxorubicin—muscle cancer	0.000861	0.0205	CcSEcCtD
Rescinnamine—Tingling sensation—Etoposide—muscle cancer	0.000816	0.0195	CcSEcCtD
Rescinnamine—Skin discolouration—Etoposide—muscle cancer	0.000726	0.0173	CcSEcCtD
Rescinnamine—Osteoporosis—Methotrexate—muscle cancer	0.000701	0.0167	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Methotrexate—muscle cancer	0.000661	0.0158	CcSEcCtD
Rescinnamine—Psoriasis—Methotrexate—muscle cancer	0.000625	0.0149	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Doxorubicin—muscle cancer	0.000572	0.0137	CcSEcCtD
Rescinnamine—Psoriasis—Doxorubicin—muscle cancer	0.000541	0.0129	CcSEcCtD
Rescinnamine—Herpes zoster—Methotrexate—muscle cancer	0.000522	0.0125	CcSEcCtD
Rescinnamine—Redness—Doxorubicin—muscle cancer	0.000504	0.012	CcSEcCtD
Rescinnamine—Gingivitis—Methotrexate—muscle cancer	0.000501	0.012	CcSEcCtD
Rescinnamine—Seborrhoeic dermatitis—Doxorubicin—muscle cancer	0.000499	0.0119	CcSEcCtD
Rescinnamine—Abscess—Methotrexate—muscle cancer	0.000497	0.0119	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Vincristine—muscle cancer	0.000464	0.0111	CcSEcCtD
Rescinnamine—Herpes zoster—Doxorubicin—muscle cancer	0.000452	0.0108	CcSEcCtD
Rescinnamine—Pharyngitis—Dactinomycin—muscle cancer	0.000452	0.0108	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Vincristine—muscle cancer	0.000446	0.0107	CcSEcCtD
Rescinnamine—Myocardial infarction—Vincristine—muscle cancer	0.000444	0.0106	CcSEcCtD
Rescinnamine—Skin discolouration—Methotrexate—muscle cancer	0.000435	0.0104	CcSEcCtD
Rescinnamine—Gingivitis—Doxorubicin—muscle cancer	0.000433	0.0103	CcSEcCtD
Rescinnamine—Abscess—Doxorubicin—muscle cancer	0.00043	0.0103	CcSEcCtD
Rescinnamine—Stinging—Doxorubicin—muscle cancer	0.00042	0.01	CcSEcCtD
Rescinnamine—Hypoaesthesia—Vincristine—muscle cancer	0.000405	0.00966	CcSEcCtD
Rescinnamine—Erythema—Dactinomycin—muscle cancer	0.000396	0.00946	CcSEcCtD
Rescinnamine—Vaginal inflammation—Methotrexate—muscle cancer	0.000393	0.00938	CcSEcCtD
Rescinnamine—Skin discolouration—Doxorubicin—muscle cancer	0.000377	0.00899	CcSEcCtD
Rescinnamine—Cough increased—Doxorubicin—muscle cancer	0.000372	0.00887	CcSEcCtD
Rescinnamine—Vaginal infection—Methotrexate—muscle cancer	0.000371	0.00886	CcSEcCtD
Rescinnamine—Lacrimation increased—Doxorubicin—muscle cancer	0.000369	0.00881	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Etoposide—muscle cancer	0.000362	0.00864	CcSEcCtD
Rescinnamine—Myocardial infarction—Etoposide—muscle cancer	0.00036	0.00859	CcSEcCtD
Rescinnamine—Back pain—Vincristine—muscle cancer	0.000342	0.00817	CcSEcCtD
Rescinnamine—Vaginal inflammation—Doxorubicin—muscle cancer	0.00034	0.00812	CcSEcCtD
Rescinnamine—Myalgia—Dactinomycin—muscle cancer	0.000337	0.00805	CcSEcCtD
Rescinnamine—Dermatitis contact—Doxorubicin—muscle cancer	0.000336	0.00803	CcSEcCtD
Rescinnamine—Discomfort—Dactinomycin—muscle cancer	0.000333	0.00796	CcSEcCtD
Rescinnamine—Hypoaesthesia—Etoposide—muscle cancer	0.000328	0.00782	CcSEcCtD
Rescinnamine—Oedema—Dactinomycin—muscle cancer	0.000323	0.00772	CcSEcCtD
Rescinnamine—Infection—Dactinomycin—muscle cancer	0.000321	0.00767	CcSEcCtD
Rescinnamine—Vaginal infection—Doxorubicin—muscle cancer	0.000321	0.00767	CcSEcCtD
Rescinnamine—Hypertension—Vincristine—muscle cancer	0.000306	0.0073	CcSEcCtD
Rescinnamine—Myalgia—Vincristine—muscle cancer	0.000301	0.00719	CcSEcCtD
Rescinnamine—Hypertonia—Doxorubicin—muscle cancer	0.000298	0.00712	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000295	0.00703	CcSEcCtD
Rescinnamine—Oedema—Vincristine—muscle cancer	0.000289	0.0069	CcSEcCtD
Rescinnamine—Infection—Vincristine—muscle cancer	0.000287	0.00685	CcSEcCtD
Rescinnamine—Dysgeusia—Etoposide—muscle cancer	0.000281	0.0067	CcSEcCtD
Rescinnamine—Back pain—Etoposide—muscle cancer	0.000277	0.00662	CcSEcCtD
Rescinnamine—Pain—Dactinomycin—muscle cancer	0.000276	0.0066	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000264	0.00631	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000263	0.00628	CcSEcCtD
Rescinnamine—Insomnia—Vincristine—muscle cancer	0.000261	0.00624	CcSEcCtD
Rescinnamine—Paraesthesia—Vincristine—muscle cancer	0.000259	0.00619	CcSEcCtD
Rescinnamine—Dermatitis bullous—Doxorubicin—muscle cancer	0.000258	0.00617	CcSEcCtD
Rescinnamine—Abdominal pain—Dactinomycin—muscle cancer	0.000256	0.0061	CcSEcCtD
Rescinnamine—Cough—Etoposide—muscle cancer	0.00025	0.00597	CcSEcCtD
Rescinnamine—Hypertension—Etoposide—muscle cancer	0.000248	0.00591	CcSEcCtD
Rescinnamine—Constipation—Vincristine—muscle cancer	0.000247	0.0059	CcSEcCtD
Rescinnamine—Pain—Vincristine—muscle cancer	0.000247	0.0059	CcSEcCtD
Rescinnamine—Discomfort—Etoposide—muscle cancer	0.000241	0.00576	CcSEcCtD
Rescinnamine—Hypersensitivity—Dactinomycin—muscle cancer	0.000238	0.00569	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vincristine—muscle cancer	0.000236	0.00564	CcSEcCtD
Rescinnamine—Infection—Etoposide—muscle cancer	0.000232	0.00555	CcSEcCtD
Rescinnamine—Abdominal pain—Vincristine—muscle cancer	0.000228	0.00545	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000225	0.00537	CcSEcCtD
Rescinnamine—Gastritis—Doxorubicin—muscle cancer	0.000219	0.00522	CcSEcCtD
Rescinnamine—Conjunctivitis—Methotrexate—muscle cancer	0.000214	0.0051	CcSEcCtD
Rescinnamine—Influenza—Doxorubicin—muscle cancer	0.000213	0.0051	CcSEcCtD
Rescinnamine—Hypersensitivity—Vincristine—muscle cancer	0.000213	0.00508	CcSEcCtD
Rescinnamine—Paraesthesia—Etoposide—muscle cancer	0.00021	0.00502	CcSEcCtD
Rescinnamine—Angina pectoris—Doxorubicin—muscle cancer	0.000208	0.00496	CcSEcCtD
Rescinnamine—Bronchitis—Doxorubicin—muscle cancer	0.000205	0.0049	CcSEcCtD
Rescinnamine—Rash—Dactinomycin—muscle cancer	0.000204	0.00487	CcSEcCtD
Rescinnamine—Pain—Etoposide—muscle cancer	0.0002	0.00478	CcSEcCtD
Rescinnamine—Constipation—Etoposide—muscle cancer	0.0002	0.00478	CcSEcCtD
Rescinnamine—Pharyngitis—Methotrexate—muscle cancer	0.000196	0.00467	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000195	0.00465	CcSEcCtD
Rescinnamine—Nausea—Dactinomycin—muscle cancer	0.000192	0.00459	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Etoposide—muscle cancer	0.000191	0.00457	CcSEcCtD
Rescinnamine—Dizziness—Vincristine—muscle cancer	0.000191	0.00456	CcSEcCtD
Rescinnamine—Urticaria—Etoposide—muscle cancer	0.000186	0.00444	CcSEcCtD
Rescinnamine—Abdominal pain—Etoposide—muscle cancer	0.000185	0.00442	CcSEcCtD
Rescinnamine—Conjunctivitis—Doxorubicin—muscle cancer	0.000185	0.00442	CcSEcCtD
Rescinnamine—Urinary tract infection—Doxorubicin—muscle cancer	0.000185	0.00442	CcSEcCtD
Rescinnamine—Rash—Vincristine—muscle cancer	0.000182	0.00435	CcSEcCtD
Rescinnamine—Dermatitis—Vincristine—muscle cancer	0.000182	0.00434	CcSEcCtD
Rescinnamine—Headache—Vincristine—muscle cancer	0.000181	0.00432	CcSEcCtD
Rescinnamine—Sinusitis—Doxorubicin—muscle cancer	0.000179	0.00426	CcSEcCtD
Rescinnamine—Hypersensitivity—Etoposide—muscle cancer	0.000172	0.00412	CcSEcCtD
Rescinnamine—Erythema—Methotrexate—muscle cancer	0.000172	0.0041	CcSEcCtD
Rescinnamine—Nausea—Vincristine—muscle cancer	0.000172	0.0041	CcSEcCtD
Rescinnamine—Rhinitis—Doxorubicin—muscle cancer	0.000171	0.00409	CcSEcCtD
Rescinnamine—Hypoaesthesia—Doxorubicin—muscle cancer	0.00017	0.00406	CcSEcCtD
Rescinnamine—Pharyngitis—Doxorubicin—muscle cancer	0.00017	0.00405	CcSEcCtD
Rescinnamine—Dysgeusia—Methotrexate—muscle cancer	0.000168	0.00402	CcSEcCtD
Rescinnamine—Back pain—Methotrexate—muscle cancer	0.000166	0.00397	CcSEcCtD
Rescinnamine—Pruritus—Etoposide—muscle cancer	0.000166	0.00395	CcSEcCtD
Rescinnamine—Dizziness—Etoposide—muscle cancer	0.000155	0.00369	CcSEcCtD
Rescinnamine—Cough—Methotrexate—muscle cancer	0.00015	0.00358	CcSEcCtD
Rescinnamine—Erythema—Doxorubicin—muscle cancer	0.000149	0.00355	CcSEcCtD
Rescinnamine—Rash—Etoposide—muscle cancer	0.000148	0.00352	CcSEcCtD
Rescinnamine—Dermatitis—Etoposide—muscle cancer	0.000147	0.00352	CcSEcCtD
Rescinnamine—Headache—Etoposide—muscle cancer	0.000147	0.0035	CcSEcCtD
Rescinnamine—Myalgia—Methotrexate—muscle cancer	0.000146	0.00349	CcSEcCtD
Rescinnamine—Dysgeusia—Doxorubicin—muscle cancer	0.000146	0.00348	CcSEcCtD
Rescinnamine—Discomfort—Methotrexate—muscle cancer	0.000144	0.00345	CcSEcCtD
Rescinnamine—Back pain—Doxorubicin—muscle cancer	0.000144	0.00343	CcSEcCtD
Rescinnamine—Infection—Methotrexate—muscle cancer	0.000139	0.00332	CcSEcCtD
Rescinnamine—Nausea—Etoposide—muscle cancer	0.000139	0.00332	CcSEcCtD
Rescinnamine—Cough—Doxorubicin—muscle cancer	0.00013	0.0031	CcSEcCtD
Rescinnamine—Hypertension—Doxorubicin—muscle cancer	0.000128	0.00307	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000128	0.00305	CcSEcCtD
Rescinnamine—Insomnia—Methotrexate—muscle cancer	0.000127	0.00303	CcSEcCtD
Rescinnamine—Myalgia—Doxorubicin—muscle cancer	0.000127	0.00302	CcSEcCtD
Rescinnamine—Paraesthesia—Methotrexate—muscle cancer	0.000126	0.003	CcSEcCtD
Rescinnamine—Discomfort—Doxorubicin—muscle cancer	0.000125	0.00299	CcSEcCtD
Rescinnamine—Oedema—Doxorubicin—muscle cancer	0.000121	0.0029	CcSEcCtD
Rescinnamine—Infection—Doxorubicin—muscle cancer	0.000121	0.00288	CcSEcCtD
Rescinnamine—Pain—Methotrexate—muscle cancer	0.00012	0.00286	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000115	0.00274	CcSEcCtD
Rescinnamine—Urticaria—Methotrexate—muscle cancer	0.000111	0.00266	CcSEcCtD
Rescinnamine—Abdominal pain—Methotrexate—muscle cancer	0.000111	0.00265	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000111	0.00264	CcSEcCtD
Rescinnamine—Insomnia—Doxorubicin—muscle cancer	0.00011	0.00262	CcSEcCtD
Rescinnamine—Paraesthesia—Doxorubicin—muscle cancer	0.000109	0.0026	CcSEcCtD
Rescinnamine—Pain—Doxorubicin—muscle cancer	0.000104	0.00248	CcSEcCtD
Rescinnamine—Constipation—Doxorubicin—muscle cancer	0.000104	0.00248	CcSEcCtD
Rescinnamine—Hypersensitivity—Methotrexate—muscle cancer	0.000103	0.00247	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Doxorubicin—muscle cancer	9.92e-05	0.00237	CcSEcCtD
Rescinnamine—Pruritus—Methotrexate—muscle cancer	9.92e-05	0.00237	CcSEcCtD
Rescinnamine—Urticaria—Doxorubicin—muscle cancer	9.64e-05	0.0023	CcSEcCtD
Rescinnamine—Abdominal pain—Doxorubicin—muscle cancer	9.59e-05	0.00229	CcSEcCtD
Rescinnamine—Dizziness—Methotrexate—muscle cancer	9.27e-05	0.00221	CcSEcCtD
Rescinnamine—Hypersensitivity—Doxorubicin—muscle cancer	8.94e-05	0.00213	CcSEcCtD
Rescinnamine—Rash—Methotrexate—muscle cancer	8.84e-05	0.00211	CcSEcCtD
Rescinnamine—Dermatitis—Methotrexate—muscle cancer	8.83e-05	0.00211	CcSEcCtD
Rescinnamine—Headache—Methotrexate—muscle cancer	8.78e-05	0.0021	CcSEcCtD
Rescinnamine—Pruritus—Doxorubicin—muscle cancer	8.59e-05	0.00205	CcSEcCtD
Rescinnamine—Nausea—Methotrexate—muscle cancer	8.33e-05	0.00199	CcSEcCtD
Rescinnamine—Dizziness—Doxorubicin—muscle cancer	8.03e-05	0.00192	CcSEcCtD
Rescinnamine—Rash—Doxorubicin—muscle cancer	7.65e-05	0.00183	CcSEcCtD
Rescinnamine—Dermatitis—Doxorubicin—muscle cancer	7.65e-05	0.00183	CcSEcCtD
Rescinnamine—Headache—Doxorubicin—muscle cancer	7.6e-05	0.00182	CcSEcCtD
Rescinnamine—Nausea—Doxorubicin—muscle cancer	7.21e-05	0.00172	CcSEcCtD
